UL Solutions director granted small deferred stock units
Shannon James M reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Shannon James M reported acquisition or exercise transactions in this Form 4 filing.
UL Solutions Inc. director Shannon James M reported three small compensation-related awards of Deferred Restricted Stock Units on June 8, 2026. These awards, totaling 14 units (3, 4, and 7), represent dividend equivalent rights that accrue on existing deferred stock holdings and cost $0.00 per unit.
Each Deferred Restricted Stock Unit represents a contingent right to receive one share of Class A Common Stock. The footnotes explain that these dividend equivalents vest in step with the underlying Deferred Restricted Stock Units and will be settled in Class A shares under the company’s Non-Employee Director Deferred Compensation Plan. After the latest grant, the director holds 4,969 Deferred Restricted Stock Units and related dividend equivalents.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Restricted Stock Units | 7 | $0.00 | $0.00 |
| Grant/Award | Deferred Restricted Stock Units | 4 | $0.00 | $0.00 |
| Grant/Award | Deferred Restricted Stock Units | 3 | $0.00 | $0.00 |
Footnotes (6)
- F1. Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2. Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.
- F3. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.
- F4. Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.
- F5. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.
- F6. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.
Key Figures
Key Terms
Deferred Restricted Stock Units financial
dividend equivalent rights financial
Non-Employee Director Deferred Compensation Plan financial
Class A Common Stock financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did UL Solutions (ULS) insider Shannon James M report in this Form 4?
How many Deferred Restricted Stock Units were granted to the UL Solutions (ULS) director?
Are the UL Solutions (ULS) Form 4 transactions open-market buys or routine compensation?
How many Deferred Restricted Stock Units does the UL Solutions (ULS) director hold after these grants?
When do the UL Solutions (ULS) deferred units and dividend equivalents vest and settle?
AI-generated analysis. How Rhea-AI works. Not financial advice.